World CDx 2026 has ended. This guide stays up as the record of who was there. Next: World CDx 2027, Aug 30 – Sep 2, 2027 in Boston
Johnson & Johnson Innovative Medicine at World CDx 2026
Oct 5–8, 2026 Boston, MA ~900 attendees Website
Johnson & Johnson Innovative Medicine takes part in 9 sessions at World CDx 2026 in Boston. Its sessions cover partnerships between drug makers and diagnostic companies and wider patient access to comprehensive genomic profiling through the Precision Cancer Consortium. They also ask whether minimal residual disease measures can work in inflammatory bowel disease, through a consortium with the Crohn's & Colitis Foundation for deeper trial endpoints.
| Organization | World CDx 2026 Attendance |
|---|---|
Johnson & Johnson Innovative Medicine New Brunswick, NJ | |
Pharmaceutical business of Johnson & Johnson, formerly Janssen, with medicines in oncology, immunology and neuroscience. | Talk Tue Oct 6 11:10am From Strategic Partnering to Orchestrated Partnering: Navigating the Next Era of Precision Medicine Drug–diagnostic commercialization & access Panel Tue Oct 6 6:10pm Strengthening Tumor‑Informed MRD Assays with Standardized Analytical Validation to Ensure Reliable Detection & Confident Clinical Interpretation Liquid biopsy & MRDClinical & companion diagnostic development Chair Wed Oct 7 11:19am Stream chair Talk Wed Oct 7 12:40pm MRD in IBD? Building a Precision Medicine Consortium for Deeper Endpoints in IBD Biomarker discovery & translation Talk Wed Oct 7 2:40pm If You Build It, Will They Come? Drug–diagnostic commercialization & access Panel Wed Oct 7 5:00pm Beyond the Contract: Inside a Pharma–CDx Partnership Clinical & companion diagnostic developmentDrug–diagnostic commercialization & access Talk Thu Oct 8 8:10am Expanding Access to Precision Cancer Care with the Precision Cancer Consortium CGP Implementation Guide Drug–diagnostic commercialization & accessClinical & companion diagnostic development Panel Thu Oct 8 9:00am Mobilizing Precision Cancer Care Through the Precision Cancer Consortium to Standardize Testing Pathways & Reduce Access Barriers Drug–diagnostic commercialization & access Panel Thu Oct 8 2:00pm Fit-for-Purpose CDx Strategies: Matching Testing Approaches to Development & Patient Access Needs Clinical & companion diagnostic developmentDrug–diagnostic commercialization & access |
Instantly find 20 buyers from Johnson & Johnson Innovative Medicine
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by World CDx or its organizers. Submit a correction